In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Management of co-morbidities in heart failure - Exploring new frontiers
Session

Event : Heart Failure 2017

Topic : Other

  • Session type : Satellite Symposium
  • Date : 30 April 2017
  • Time : 12:45 - 14:00
  • Sponsored by Bayer AG

6 presentations in this session

Introduction & remarks.

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : N Danchin (Montreuil,FR)
  • Sponsored by Bayer AG

Expanding the evidence for rivaroxaban in Atrial Fibrillation (AF) patients with comorbidites including Heart Failure (HF): from Randomized Controlled Trials (RCT) to Real World Evidence (RWE).

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : M Cowie (London,GB)
  • Sponsored by Bayer AG

Options in thrombosis prevention and vascular health – What’s on the horizon?

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Broadening the evidence base for rivaroxaban in heart failure.

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : B Greenberg (La Jolla,US)
  • Sponsored by Bayer AG

Exploring new frontiers: is it time for a comorbidity-based approach in heart failure?

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : R Mentz (Durham,US)
  • Sponsored by Bayer AG

Q&A and closing remarks.

Event : Heart Failure 2017

  • Session : Management of co-morbidities in heart failure - Exploring new frontiers
  • Speaker : M Cowie (London,GB)
  • Sponsored by Bayer AG

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are